Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s10067-022-06247-3.pdf
Reference22 articles.
1. Arnold J, Winthrop K, Emery P (2021) COVID-19 vaccination and antirheumatic therapy. Rheumatology 60:3496–3502. https://doi.org/10.1093/rheumatology/keab223
2. Bartels LE, Ammitzbøll C, Andersen JB et al (2021) Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int 41:1925–1931. https://doi.org/10.1007/s00296-021-04972-7
3. Vaccine information, ICMR New delhi - COVID-19 Vaccine. https://vaccine.icmr.org.in/covid-19-vaccine. Accessed 30 Mar 2022
4. Voysey M, Clemens SAC, Madhi SA et al (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397:99–111. https://doi.org/10.1016/S0140-6736(20)32661-1
5. D’Amelio R, Asero R, Cassatella MA et al (2021) Anti-COVID-19 vaccination in patients with autoimmune-autoinflammatory disorders and primary/secondary immunodeficiencies: the position of the Task Force on Behalf of the Italian Immunological Societies. Biomedicines 9:1163. https://doi.org/10.3390/biomedicines9091163
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis;Vaccines;2023-09-04
2. The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study;Human Vaccines & Immunotherapeutics;2023-08
3. Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review;World Journal of Diabetes;2023-06-15
4. Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV;Frontiers in Immunology;2023-03-02
5. Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity;Rheumatology International;2022-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3